Chemical
Moxifloxacin EP Impurity A
1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS: 151213-15-9
Formula: C₂₀H₂₁F₂N₃O₃
Specifications
Key details (from tblproducts)
| CAS | 151213-15-9 |
| Category | Therapeutic |
| Molecular formula | C₂₀H₂₁F₂N₃O₃ |
| Molecular weight | 389.40 |
| IUPAC | 1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| Smileys | O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3F)C1=O)O |
Supplier listings below are pulled from tblproductsupplier + tblsuppliers.
Suppliers
Suppliers offering this product
| Supplier | Country | Stock | Action |
|---|---|---|---|
| Clearsynth | India | In Stock | View |
| Aozeal Certified Standards | United States | In Stock | View |
| GVP Bio Life Sciences | INDIA | In Stock | View |
| VD Research Chem | India | In Stock | View |
| BNB LIFE SCIENCES | India | In Stock | View |
| Broad Pharmaceutical Co., Ltd | China | — | View |
| chemicea pharmaceuticals pvt ltd | India | In Stock | View |
| Chemikos laboratories pvt ltd | India | In Stock | View |
| Glyra Healthcare Pvt. Ltd | India | In Stock | View |
| Goalsy Pharma Pvt Ltd. | India | In Stock | View |
| Guangzhou Tosun Pharmaceutical Ltd | China | In Stock | View |
| R K CHEMICALS | India | In Stock | View |
| RAVI PHARMA | India | In Stock | View |